Frola CE, Aristegui I, Figueroa MI, Radusky PD, et al. Retention among transgender women treated with dolutegravir associated with tenofovir/lamivudine or emtricitabine in Argentina: TransViiV study. PLoS One 2023;18:e0279996.
PMID: 36662723